Literature DB >> 19924423

The neuropathologic substrate of Parkinson disease dementia.

Kurt A Jellinger.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19924423     DOI： 10.1007/s00401-009-0613-1

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN： 0001-6322            Impact factor:   17.088


× No keyword cloud information.
  10 in total

Review 1.  Neuropathobiology of non-motor symptoms in Parkinson disease.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2015-05-15       Impact factor: 3.575

Review 2.  Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2017-12-08       Impact factor: 3.575

3.  Significance of cerebral amyloid angiopathy and other co-morbidities in Lewy body diseases.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2021-04-29       Impact factor: 3.575

Review 4.  Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases.

Authors:  Alberto Lleó; Enrica Cavedo; Lucilla Parnetti; Hugo Vanderstichele; Sanna Kaisa Herukka; Niels Andreasen; Roberta Ghidoni; Piotr Lewczuk; Andreas Jeromin; Bengt Winblad; Magda Tsolaki; Barbara Mroczko; Pieter Jelle Visser; Isabel Santana; Per Svenningsson; Kaj Blennow; Dag Aarsland; José Luis Molinuevo; Henrik Zetterberg; Brit Mollenhauer
Journal:  Nat Rev Neurol       Date:  2014-12-16       Impact factor: 42.937

Review 5.  Mild cognitive impairment in Parkinson disease: heterogenous mechanisms.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2012-02-18       Impact factor: 3.575

6.  Reply: Matters Arising 'Lewy body disease or diseases with Lewy bodies?'

Authors:  Kateřina Menšíková; Radoslav Matěj; Carlo Colosimo; Raymond Rosales; Lucie Tučková; Jiří Ehrmann; Dominik Hraboš; Kristýna Kolaříková; Radek Vodička; Radek Vrtěl; Martin Procházka; Martin Nevrlý; Michaela Kaiserová; Sandra Kurčová; Pavel Otruba; Petr Kaňovský
Journal:  NPJ Parkinsons Dis       Date:  2022-06-23

Review 7.  Neuroimmune Tau Mechanisms: Their Role in the Progression of Neuronal Degeneration.

Authors:  Nicole Cortés; Víctor Andrade; Leonardo Guzmán-Martínez; Matías Estrella; Ricardo B Maccioni
Journal:  Int J Mol Sci       Date:  2018-03-23       Impact factor: 5.923

Review 8.  Neuroinflammation as a Common Feature of Neurodegenerative Disorders.

Authors:  Leonardo Guzman-Martinez; Ricardo B Maccioni; Víctor Andrade; Leonardo Patricio Navarrete; María Gabriela Pastor; Nicolas Ramos-Escobar
Journal:  Front Pharmacol       Date:  2019-09-12       Impact factor: 5.810

Review 9.  A Possible Role for HMG-CoA Reductase Inhibitors and Its Association with HMGCR Genetic Variation in Parkinson's Disease.

Authors:  Anna Pierzchlińska; Marek Droździk; Monika Białecka
Journal:  Int J Mol Sci       Date:  2021-11-11       Impact factor: 5.923

10.  Matters Arising 'Lewy body disease or diseases with Lewy bodies?'

Authors:  Kurt A Jellinger
Journal:  NPJ Parkinsons Dis       Date:  2022-06-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.